These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12591134)

  • 1. Alteration of zinc concentrations in the brain implanted with C6 glioma.
    Takeda A; Tamano H; Oku N
    Brain Res; 2003 Mar; 965(1-2):170-3. PubMed ID: 12591134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential uptake of zinc, manganese, and rubidium in rat brain tumor.
    Tamano H; Enomoto S; Oku N; Takeda A
    Nucl Med Biol; 2002 May; 29(4):505-8. PubMed ID: 12031887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-65 imaging of rat brain tumors.
    Takeda A; Tamano H; Enomoto S; Oku N
    Cancer Res; 2001 Jul; 61(13):5065-9. PubMed ID: 11431342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of zinc uptake under growth arrest and apoptosis.
    Takeda A; Tamano H; Ibuki Y
    Anticancer Res; 2004; 24(6):3869-74. PubMed ID: 15736424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydrogen sulfide stimulates the development of rat glioblastoma].
    Li ZY; Liu SC; Xu PJ; Yang Z; Zhang T
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):254-8. PubMed ID: 22781035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 65Zn localization in rat brain after intracerebroventricular injection of 65Zn-histidine.
    Takeda A; Suzuki M; Okada S; Oku N
    Brain Res; 2000 Apr; 863(1-2):241-4. PubMed ID: 10773212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
    Dave N; Gudelsky GA; Desai PB
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):349-57. PubMed ID: 23748921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
    Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
    Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperpolarized (129)Xe spectra from C6 glioma cells implanted in rat brains.
    Nakamura K; Kondoh Y; Kinoshita T
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():2972-5. PubMed ID: 24110351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of phagocytosis in experimental gliomas.
    Zimmer C; Weissleder R; Poss K; Bogdanova A; Wright SC; Enochs WS
    Radiology; 1995 Nov; 197(2):533-8. PubMed ID: 7480707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate.
    Dienel GA; Popp D; Drew PD; Ball K; Krisht A; Cruz NF
    J Nucl Med; 2001 Aug; 42(8):1243-50. PubMed ID: 11483687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Facilitated" amino acid transport is upregulated in brain tumors.
    Miyagawa T; Oku T; Uehara H; Desai R; Beattie B; Tjuvajev J; Blasberg R
    J Cereb Blood Flow Metab; 1998 May; 18(5):500-9. PubMed ID: 9591842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results.
    Noell S; Mayer D; Strauss WS; Tatagiba MS; Ritz R
    Int J Oncol; 2011 May; 38(5):1343-8. PubMed ID: 21399870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of zinc from the brain of El (epilepsy) mice during seizure induction.
    Takeda A; Hanajima T; Ijiro H; Ishige A; Iizuka S; Okada S; Oku N
    Brain Res; 1999 May; 828(1-2):174-8. PubMed ID: 10320739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
    Devineni D; Klein-Szanto A; Gallo JM
    Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain uptake of trace metals, zinc and manganese, in rats.
    Takeda A; Akiyama T; Sawashita J; Okada S
    Brain Res; 1994 Mar; 640(1-2):341-4. PubMed ID: 8004463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
    Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
    Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.